Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation

Background: Acute lung injury (ALI) is characterized by dysfunction of the alveolar epithelial membrane caused by acute inflammation and tissue injury. Qingwenzhike (QWZK) prescription has been demonstrated to be effective against respiratory viral infections in clinical practices, including coronav...

Cijeli opis

Bibliografski detalji

Glavni autori:	Cai Zhang, Xinran Wang, Chunguo Wang, Cheng He, Quantao Ma, Jialin Li, Weiling Wang, Yan-Tong Xu, Ting Wang
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2021-12-01
Serija:	Frontiers in Pharmacology
Teme:	Acute Lung Injury (ALI) Qingwenzhike (QWZK) prescription inflammation cytokines TLR4/NF-κB signaling pathway inflammasome NLRP3
Online pristup:	https://www.frontiersin.org/articles/10.3389/fphar.2021.790072/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!